Enhanced anti-tumor activity by the combination of the natural compounds (-)-epigallocatechin-3-gallate and luteolin: Potential role of p53

Journal of Biological Chemistry

Volumn 285, Issue 45, 2010, Pages 34557-34565

  Ruhul Amin, A R M ^a   Wang, Dongsheng ^a   Zhang, Hongzheng ^a   Peng, Shifang ^a   Shin, Hyung Ju C ^b   Brandes, Johann C ^a   Tighiouart, Mourad ^a   Khuri, Fadlo R ^a   Chen, Zhuo Georgia ^a   Shin, Dong M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADP-RIBOSE; AFTER-TREATMENT; ANTI-TUMOR ACTIVITIES; APOPTOSIS; CANCER PREVENTION; CASPASE-3; CELL LINES; CHEMOPREVENTION; CHEMOPREVENTIVE AGENTS; CLINICAL TRIAL; COMBINATORIAL APPROACH; DNA DAMAGES; EPIGALLOCATECHIN-3-GALLATE; HEAD AND NECK; IN-VIVO; INHIBITED GROWTH; INHIBITORY EFFECT; LOW DOSE; LUNG CANCER; LUNG CANCER CELLS; MECHANISTIC STUDIES; MITOCHONDRIAL TRANSLOCATION; NATURAL COMPOUNDS; NUDE MICE; POLYPHENOLS; SAFETY MARGIN; SINGLE-AGENT;

BIOLOGICAL ORGANS; CELL CULTURE; MITOCHONDRIA; PHENOLS; PHOSPHORYLATION; TUMORS;

CELL DEATH;

CASPASE 3; EPIGALLOCATECHIN GALLATE; KI 67 ANTIGEN; LUTEOLIN; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; LUNG CANCER; MITOCHONDRION; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; TREATMENT RESPONSE; TUMOR XENOGRAFT;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; CASPASE 3; CATECHIN; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DNA DAMAGE; DNA-BINDING PROTEINS; DRUG SYNERGISM; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; KI-67 ANTIGEN; LUTEOLIN; MICE; MICE, NUDE; MITOCHONDRIA; NEOPLASM TRANSPLANTATION; PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS MUSCULUS;

EID: 78049398239     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M110.141135     Document Type: Article

References (42)

1. Hong, W. K., and Sporn, M. B. (1997) Science 278, 1073-1077
2. Hawk, E., Lubet, R., and Limburg, P. (1999) Cancer 86, 2551-2563
3. Antonakopoulos, N., and Karamanolis, D. G. (2007) Hepatogastroenterology 54, 1694-1700
4. Fabian, C. J., and Kimler, B. F. (2005) J. Clin. Oncol. 23, 1644-1655
5. Peng, J., Sengupta, S., and Jordan, V. C. (2009) Anticancer Agents Med. Chem. 9, 481-499
6. Torrance, C. J., Jackson, P. E., Montgomery, E., Kinzler, K. W., Vogelstein, B., Wissner, A., Nunes, M., Frost, P., and Discafani, C. M. (2000) Nat. Med. 6, 1024-1028
7. Meyskens, F. L., Jr., McLaren, C. E., Pelot, D., Fujikawa-Brooks, S., Carpenter, P. M., Hawk, E., Kelloff, G., Lawson, M. J., Kidao, J., McCracken, J., Albers, C. G., Ahnen, D. J., Turgeon, D. K., Goldschmid, S., Lance, P., Hagedorn, C. H., Gillen, D. L., and Gerner, E. W. (2008) Cancer Prev. Res. 1, 32-38
8. Amin, A. R., Khuri, F. R., Chen, Z. G., and Shin, D. M. (2009) Cancer Prev. Res. 2, 538-545
9. Zhang, X., Zhang, H., Tighiouart, M., Lee, J. E., Shin, H. J., Khuri, F. R., Yang, C. S., Chen, Z. G., and Shin, D. M. (2008) Int. J. Cancer 123, 1005-1014
10. Zhang, X., Chen, Z. G., Choe, M. S., Lin, Y., Sun, S. Y., Wieand, H. S., Shin, H. J., Chen, A., Khuri, F. R., and Shin, D. M. (2005) Clin. Cancer Res. 11, 6261-6269
11. Amin, A. R., Kucuk, O., Khuri, F. R., and Shin, D. M. (2009) J. Clin. Oncol. 27, 2712-2725
12. Cheng, A. L., Hsu, C. H., Lin, J. K., Hsu, M. M., Ho, Y. F., Shen, T. S., Ko, J. Y., Lin, J. T., Lin, B. R., Ming-Shiang, W., Yu, H. S., Jee, S. H., Chen, G. S., Chen, T. M., Chen, C. A., Lai, M. K., Pu, Y. S., Pan, M. H., Wang, Y. J., Tsai, C. C., and Hsieh, C. Y. (2001) Anticancer Res. 21, 2895-2900
13. Pisters, K. M., Newman, R. A., Coldman, B., Shin, D. M., Khuri, F. R., Hong, W. K., Glisson, B. S., and Lee, J. S. (2001) J. Clin. Oncol. 19, 1830-1838
14. Shanafelt, T. D., Call, T. G., Zent, C. S., LaPlant, B., Bowen, D. A., Roos, M., Secreto, C. R., Ghosh, A. K., Kabat, B. F., Lee, M. J., Yang, C. S., Jelinek, D. F., Erlichman, C., and Kay, N. E. (2009) J. Clin. Oncol. 27, 3808-3814
15. Tsao, A. S., Liu, D., Martin, J., Tang, X. M., Lee, J. J., El-Naggar, A. K., Wistuba, I., Culotta, K. S., Mao, L., Gillenwater, A., Sagesaka, Y. M., Hong, W. K., and Papadimitrakopoulou, V. (2009) Cancer Prev. Res. 2, 931-941
16. Nakagawa, K., Okuda, S., and Miyazawa, T. (1997) Biosci. Biotechnol. Biochem. 61, 1981-1985
17. Yang, C. S., Chen, L., Lee, M. J., Balentine, D., Kuo, M. C., and Schantz, S. P. (1998) Cancer Epidemiol. Biomarkers. Prev. 7, 351-354
18. Lee, M. J., Maliakal, P., Chen, L., Meng, X., Bondoc, F. Y., Prabhu, S., Lambert, G., Mohr, S., and Yang, C. S. (2002) Cancer. Epidemiol. Biomarkers. Prev. 11, 1025-1032
19. Chow, H. H., Cai, Y., Alberts, D. S., Hakim, I., Dorr, R., Shahi, F., Crowell, J. A., Yang, C. S., and Hara, Y. (2001) Cancer Epidemiol. Biomarkers. Prev. 10, 53-58
20. Hou, Z., Sang, S., You, H., Lee, M. J., Hong, J., Chin, K. V., and Yang, C. S. (2005) Cancer Res. 65, 8049-8056
21. Miean, K. H., and Mohamed, S. (2001) J. Agric. Food. Chem. 49, 3106-3112
22. Shimoi, K., Saka, N., Kaji, K., Nozawa, R., and Kinae, N. (2000) Biofactors 12, 181-186
23. Sun, S. Y., Yue, P., Dawson, M. I., Shroot, B., Michel, S., Lamph, W. W., Heyman, R. A., Teng, M., Chandraratna, R. A., Shudo, K., Hong, W. K., and Lotan, R. (1997) Cancer Res. 57, 4931-4939
24. Wiznerowicz, M., and Trono, D. (2003) J. Virol. 2, 8957-8961
25. Ciardiello, F., Bianco, R., Damiano, V., De Lorenzo, S., Pepe, S., De Placido, S., Fan, Z., Mendelsohn, J., Bianco, A. R., and Tortora, G. (1999) Clin. Cancer Res. 5, 909-916
26. Ahmad, N., Feyes, D. K., Nieminen, A. L., Agarwal, R., and Mukhtar, H. (1997) J. Natl. Cancer Inst. 89, 1881-1886
27. Sahu, R. P., and Srivastava, S. K. (2009) J. Natl. Cancer Inst. 101, 176-193
28. Feng, L., Lin, T., Uranishi, H., Gu, W., and Xu, Y. (2005) Mol. Cell. Biol. 25, 5389-5395
29. Bode, A. M., and Dong, Z. (2004) Nat. Rev. Cancer 4, 793-805
30. Carter, S., and Vousden, K. H. (2009) Curr. Opin. Genet. Dev. 19, 18-24
31. Bonner, W. M., Redon, C. E., Dickey, J. S., Nakamura, A. J., Sedelnikova, O. A., Solier, S., and Pommier, Y. (2008) Nat. Rev. Cancer 8, 957-967
32. Thakur, V. S., Ruhul Amin, A. R., Paul, R. K., Gupta, K., Hastak, K., Agarwal, M. K., Jackson, M. W., Wald, D. N., Mukhtar, H., and Agarwal, M. L. (2010) Cancer Lett. 296, 225-232
33. Vaseva, A. V., and Moll, U. M. (2009) Biochim. Biophys. Acta 1787, 414-420
34. Marchenko, N. D., and Moll, U. M. (2007) Cell Cycle 6, 1718-1723
35. Shin, D. M. (2009) Cancer Prev. Res. 2, 919-921
36. Horinaka, M., Yoshida, T., Shiraishi, T., Nakata, S., Wakada, M., Nakanishi, R., Nishino, H., Matsui, H., and Sakai, T. (2005) Oncogene 24, 7180-7189
37. Horinaka, M., Yoshida, T., Shiraishi, T., Nakata, S., Wakada, M., Nakanishi, R., Nishino, H., and Sakai, T. (2005) Biochem. Biophys. Res. Commun. 333, 833-838
38. Roy, S. S., Ehrlich, A. M., Craigen, W. J., and Hajnóczky, G. (2009) EMBO. Rep. 10, 1341-1347
39. Zhao, Y., Li, R., Xia, W., Neuzil, J., Lu, Y., Zhang, H., Zhao, X., Zhang, X., Sun, C., and Wu, K. (2010) Cancer Lett. 288, 42-49
40. Qin, J., Chen, H. G., Yan, Q., Deng, M., Liu, J., Doerge, S., Ma, W., Dong, Z., and Li, D. W. (2008) Cancer Res. 68, 4150-4162
41. Meslin, F., Thiery, J., Richon, C., Jalil, A., and Chouaib, S. (2007) J. Biol. Chem. 282, 32991-32999
42. Bode, A. M., and Dong, Z. (2009) Cancer Prev. Res. 2, 514-517